A Zenix Product
SITAGLENIX-M 50/500
Description
Primary Adjunctive Therapy: Prescribed alongside a structured dietary plan and regular physical exercise to improve glycemic control when lifestyle changes alone do not sufficiently lower blood glucose levels.
Indications
- Type 2 Diabetes Mellitus: Controls high blood sugar levels when diet and exercise are not enough.
- Combination Therapy: Used as an add-on or second-line treatment when single drugs (like metformin or sitagliptin alone) fail to control glucose
- Insulin Resistance: Improves the body's sensitivity to insulin and lowers glucose production in the liver
Related Products
SITAGLENIX-M 50/500
• Sitagliptin Phosphate: 50 mg • Metformin Hydrochloride (Sustained Release): 500 mg